We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+3.25%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$10B
AUM Growth
+$477M
(+5%)
Cap. Flow
+$229M
Cap. Flow
% of AUM
2.28%
Top 10 Holdings %
Top 10 Hldgs %
15.52%
Holding
1,590
New
33
Increased
385
Reduced
1,013
Closed
155
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$44.7M |
| 2 |
Microsoft
MSFT
|
+$33M |
| 3 |
Amazon
AMZN
|
+$25.1M |
| 4 |
Meta Platforms (Facebook)
META
|
+$24.1M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$21M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
YHOO
Yahoo Inc
YHOO
|
+$14.4M |
| 2 |
VAL
Valspar
VAL
|
+$10M |
| 3 |
3M
MMM
|
+$9.22M |
| 4 |
Goldman Sachs
GS
|
+$8.07M |
| 5 |
McDonald's
MCD
|
+$8.07M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.02% |
| 2 | Healthcare | 14.76% |
| 3 | Technology | 13.2% |
| 4 | Consumer Staples | 11.05% |
| 5 | Industrials | 10.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
976
Amphastar Pharmaceuticals
AMPH
$832M
| $486K | ﹤0.01% |
27,215
-2,283
| -8% | -$36.2K |
|
|
ODP
977
DELISTED
ODP
ODP
| $482K | ﹤0.01% |
8,544
-2,712
| -24% | -$139K |
|
|
LNCE
978
DELISTED
Snyders-Lance, Inc.
LNCE
| $481K | ﹤0.01% |
13,899
-2,817
| -17% | -$103K |
|
979
Copart
CPRT
$25.2B
| $480K | ﹤0.01% |
60,412
-11,300
| -16% | -$86.6K |
|
980
Lumentum
LITE
$64.9B
| $471K | ﹤0.01% |
8,253
-167
| -2% | -$8.96K |
|
|
PFPT
981
DELISTED
Proofpoint, Inc.
PFPT
| $469K | ﹤0.01% |
5,396
-329
| -6% | -$27.1K |
|
|
GRUB
982
DELISTED
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
| $469K | ﹤0.01% |
5,373
-291
| -5% | -$24.1K |
|
983
Service Corp International
SCI
$10.9B
| $468K | ﹤0.01% |
14,000
-2,767
| -17% | -$88.2K |
|
|
ELLI
984
DELISTED
Ellie Mae Inc
ELLI
| $466K | ﹤0.01% |
4,236
-338
| -7% | -$36.6K |
|
985
Workday
WDAY
$31.6B
| $465K | ﹤0.01% |
4,796
+1,906
| +66% | +$178K |
|
|
RVNC
986
DELISTED
Revance Therapeutics, Inc.
RVNC
| $463K | ﹤0.01% |
17,521
-482
| -3% | -$10.7K |
|
|
STL
987
DELISTED
Sterling Bancorp
STL
| $463K | ﹤0.01% |
19,906
-1,683
| -8% | -$38.5K |
|
|
ONC
988
BeOne Medicines Ltd
ONC
$33.9B
| $455K | ﹤0.01% |
10,118
+246
| +2% | +$9.69K |
|
|
INVX
989
Innovex International
INVX
$1.86B
| $454K | ﹤0.01% |
9,299
+2,910
| +46% | +$150K |
|
990
Lamb Weston
LW
$6.79B
| $453K | ﹤0.01% |
10,278
-1,981
| -16% | -$87K |
|
|
MDRX
991
DELISTED
Veradigm Inc. Common Stock
MDRX
| $452K | ﹤0.01% |
35,456
+15,845
| +81% | +$192K |
|
|
CYS
992
DELISTED
CYS Investments Inc.
CYS
| $451K | ﹤0.01% |
53,673
-5,068
| -9% | -$42.6K |
|
993
Palo Alto Networks
PANW
$265B
| $450K | ﹤0.01% |
20,172
+7,140
| +55% | +$144K |
|
|
KDNY
994
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $450K | ﹤0.01% |
7,897
-91
| -1% | -$4.57K |
|
|
DBVT
995
DBV Technologies
DBVT
$820M
| $447K | ﹤0.01% |
1,252
-60
| -5% | -$20.5K |
|
996
LivaNova
LIVN
$4.32B
| $446K | ﹤0.01% |
+7,285
| New | +$412K |
|
997
ON Semiconductor
ON
$35.1B
| $445K | ﹤0.01% |
31,668
+5,927
| +23% | +$89.1K |
|
998
Travere Therapeutics
TVTX
$5.27B
| $445K | ﹤0.01% |
22,972
-1,335
| -5% | -$24.2K |
|
999
Commault Systems
CVLT
$5.85B
| $443K | ﹤0.01% |
7,844
-1,077
| -12% | -$58.9K |
|
1000
PTC Therapeutics
PTCT
$6.51B
| $442K | ﹤0.01% |
24,115
+1,970
| +9% | +$26.5K |
|
Similar funds
ProShare Advisors's Q2 2017 Portfolio in Review
As of Q2 2017, ProShare Advisors held 1,590 positions worth $10B, up 5% from $9.56B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
ProShare Advisors's Q2 2017 filing shows 33 new, 385 increased, 1,013 reduced and 155 closed positions. Its largest new stake was Westwood Holdings Group: 133,198 shares worth $7.55M. The largest sale was Yahoo Inc, an estimated $14.4M.
By sector, the portfolio is most concentrated in Financials at 15% of assets, down from 16% a quarter earlier, followed by Healthcare and Technology.
- ProShare Advisors's largest Q2 2017 buy was Westwood Holdings Group: 133,198 shares worth $7.55M.
- ProShare Advisors added most to Apple in Q2 2017, an estimated $44.7M increase.
- ProShare Advisors's biggest Q2 2017 reduction was 3M, cutting an estimated $9.22M.
- ProShare Advisors fully exited Yahoo Inc in Q2 2017, selling an estimated $14.4M.
- ProShare Advisors's ten largest holdings make up 16% of its $10B portfolio in Q2 2017.
- ProShare Advisors opened 33 new positions and closed 155 in Q2 2017.
- ProShare Advisors's portfolio value rose 5% quarter-over-quarter to $10B.
Based on ProShare Advisors's 13F filing for Q2 2017, filed 11 Aug 2017.